Bell Rock Capital LLC T2 Biosystems, Inc. Transaction History

Bell Rock Capital LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 31, 2019	SELL	$1.47 - $3.16 $500,351 - $1.08 Million	-340,375 Closed	0 $0
Q1 2019 Apr 08, 2019	BUY	$2.56 - $4.48 $46,694 - $81,715	18,240 Added 5.66%	340,375 $897,000
Q4 2018 Jan 25, 2019	BUY	$2.98 - $6.86 $90,294 - $207,858	30,300 Added 10.38%	322,135 $971,000
Q3 2018 Nov 14, 2018	BUY	$5.36 - $7.83 $277,380 - $405,202	51,750 Added 21.55%	291,835 $2.18 Million
Q2 2018 Nov 14, 2018	BUY	$5.97 - $9.58 $321,932 - $516,601	53,925 Added 28.97%	240,085 $1.86 Million
Q1 2018 Nov 14, 2018	BUY	$4.21 - $7.0 $203,385 - $338,170	48,310 Added 35.05%	186,160 $1.2 Million
Q4 2017 Nov 13, 2018	BUY	$3.73 - $4.6 $241,890 - $298,310	64,850 Added 88.84%	137,850 $564,000
Q3 2017 Dec 06, 2018	BUY	$3.9 - $6.78 $276,900 - $481,380	71,000 Added 3550.0%	73,000 $304,000
Q2 2017 Dec 06, 2018	BUY	N/A	2,000	2,000 $6,000

Ticker TTOO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 7,050,850
Market Cap $15.9M
Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...

Get notified when there are updates to the investment portfolio of Bell Rock Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Bell Rock Capital LLC with notifications on news.